Research into ovarian cancer could lead to potential life-saving measures.
Ovarian cancer is the fifth most common cancer for women—but one of the most deadly. In 2017, approximately 2,800 Canadian women were diagnosed with ovarian cancer1, and an estimated 1,800 lost their lives to the disease. While survival rates are slowly increasing, early diagnosis and treatment dramatically improves a woman’s chance of survival.
Vancouver Coastal Health Research Institute researcher Dr. David Huntsman is investigating prevention and treatment strategies for clear cell carcinoma of the ovary, the second most common type of ovarian cancer. He and his research team recently received a $1.25-million 2017 Impact Grant—one of Canada’s premier cancer research grants—from the Canadian Cancer Society to support their work.
